How to Apply for the Hexagon Nutrition IPO: Step-by-Step Investment Guide

    Summary:
     

    Hexagon Nutrition Ltd. is a nutrition-focused company engaged in the development, manufacturing, and distribution of nutrition and wellness products. The Hexagon Nutrition IPO will open for subscription on June 5, 2026, and close on June 9, 2026. The IPO comprises 3,08,59,704 equity shares with a price band of ₹42 to ₹45 per share and a lot size of 333 shares.

    Hexagon Nutrition Ltd. is a nutrition-focused company engaged in the research, development, manufacturing, and distribution of a range of nutrition products. Its portfolio includes micronutrient premixes, clinical and therapeutic nutrition products, branded wellness solutions, ready-to-use foods, and micronutrient powders. Through its distribution network and export operations, the company has established a presence across domestic and international markets. The company operates across various segments of the nutrition industry, including food fortification, wellness nutrition, clinical nutrition, and malnutrition management. Its products are distributed through pharmacies, hospitals, e-commerce platforms, online pharmacies, and institutional channels. With manufacturing capabilities, research infrastructure, and an international footprint, the company participates in both domestic and export markets. Its diversified product portfolio and integrated business model enable it to address nutritional requirements across different customer categories and geographies.

    Investors can apply for the Hexagon Nutrition Ltd IPO through the ASBA (Application Supported by Blocked Amount) facility offered by banks or through their stockbroker's online trading platform. To submit an application, investors need an active PAN, Demat account, and trading account. During the IPO subscription period, applicants can log in to their preferred investment platform, select the Hexagon Nutrition Ltd IPO from the list of available public issues, enter the desired bid quantity, and confirm the application after reviewing the details. Once the application is submitted, the corresponding amount is blocked in the investor's bank account until the allotment process is completed. If shares are allotted, the amount is debited, and the shares are credited to the investor's Demat account. In case of non-allotment or partial allotment, the remaining blocked funds are released as per the applicable process. Investors should carefully review the Red Herring Prospectus and all relevant disclosures before making an investment decision.

    For more details, visit the Hexagon Nutrition IPO page.

    Hexagon Nutrition IPO Details and Objectives

    Details

    Information

    IPO Date

    June 5, 2026 to June 9, 2026

    Issue Size

    3,08,59,704 shares (agg. up to ₹138.87 Cr)

    Price Band

    ₹42 to ₹45 per share

    Lot Size

    333 shares

    Listing At

    BSE, NSE

    Purpose of the IPO

    • Carry out the offer for sale of up to 30,859,704 equity shares 

    • Achieve the benefits of listing the equity shares on the stock exchanges 

    Timeline of Hexagon Nutrition IPO

    Event

    Date

    IPO Open Date

    Fri, Jun 5, 2026 

    IPO Close Date

    Tue, Jun 9, 2026

    Tentative Allotment

    Wed, Jun 10, 2026

    Initiation of Refunds

    Thu, Jun 11, 2026

    Credit of Shares to Demat

    Thu, Jun 11, 2026 

    Tentative Listing Date

    Fri, Jun 12, 2026

    Cut-off time for UPI mandate confirmation

    5 PM on Tue, Jun 9, 2026

    Pricing & Lot Size of Hexagon Nutrition IPO

    Price Band for the IPO

    • ₹42 to ₹45 per share 

    Minimum Lot Size and Application Details

    Application

    Lots

    Shares

    Amount

    Retail (Min)

    1

    333

    ₹14,985

    Retail (Max)

    13

    4,329

    ₹1,94,805

    S-HNI (Min)

    14

    4,662

    ₹2,09,790

    S-HNI (Max)

    66

    21,978

    ₹9,89,010

    B-HNI (Min)

    67

    22,311

    ₹10,03,995

    Hexagon Nutrition IPO Application Process

    The Hexagon Nutrition IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

    Step 1: Login to Your Trading Platform

    Access your trading account using the trading platform.

    Step 2: Navigate to the IPO Section

    Go to the IPO section to view active IPO listings.

    Step 3: Select the Open IPO and Click Apply

    Locate Hexagon Nutrition IPO in the list of available IPOs and click the ‘Apply’ button.

    Step 4: Enter the Quantity of Shares You Wish to Apply For

    Specify the number of shares (lot size: 333 shares) at the price band of ₹42 to ₹45 per share.

    Step 5: Provide Your UPI ID

    Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.

    Step 6: Confirm the Application

    Review your application details and confirm the UPI mandate before 5 PM on the last application day.

    Step 7: Complete the Process and Wait for IPO Allotment Status

    Submit the application and monitor the allotment status to check if shares have been allocated to you.

    Shares Offered in Hexagon Nutrition IPO

    The allocation of shares in the Hexagon Nutrition IPO is structured across investor categories in line with applicable regulatory requirements. The issue provides defined reservations for qualified institutional buyers, non-institutional investors, and retail individual investors, with each category allotted a specified proportion of the net issue. This allocation framework outlines how the shares offered are distributed among different classes of investors.

    Investor Category

    Shares Offered

    Anchor Investors

    92,57,911 (30.00%)

    Non-Institutional Investor

    46,28,956 (15.00%)

    Qualified Institutional Buyers

    61,71,941 (20.00%)

    Retail Individual Investor

    1,08,00,896 (35.00%)

    Total Shares Offered

    3,08,59,704 (100.00%)

    This structure reflects the allocation approach as disclosed in the issue documents, indicating the proportion of shares available to each investor category.

    Financial Health and Performance

    Key Financial Metrics

    • Total Assets: Declined from ₹288.90 crore in FY23 to ₹261.36 crore as of March 2025.

    • Total Income: Recorded at ₹331.29 crore in March 2025, as compared to ₹281.65 crore in FY23.

    • Profit After Tax (PAT): Reported at ₹24.38 crore in March 2025, and ₹5.82 crore in FY23.

    • Net Worth: Recorded at ₹195.60 crore in March 2025 compared to ₹163.84 crore in FY23.

    • Reserves & Surplus: Stood at ₹183.89 crore in March 2025, as compared to ₹152.30 crore in FY23.

    • Total Borrowings: Stood at ₹26.60 crore in March 2025, as compared to ₹51.87 crore in FY23.

    • EBITDA: Stood at ₹40.07 crore in March 2025 in comparison to ₹17.17 crore in FY23.

    Recent Performance and Growth Prospects

    • The company reported growth in total income during the reviewed period across its nutrition and healthcare product segments.

    • Profitability improved over the period, indicating changes in earnings performance and operational efficiency.

    • The company’s net worth increased, reflecting the strengthening of its financial position through retained earnings and business operations.

    • Growth in reserves and surplus suggests an accumulation of earnings within the business, contributing to the company’s capital base.

    • The company reduced its overall borrowings, which may support a more balanced capital structure and lower dependence on external debt.

    • Operating earnings showed improvement during the period, reflecting developments in the company’s manufacturing, distribution, and product portfolio activities.

    • Total assets declined during the review period, while the company continued to operate across multiple nutrition categories and domestic as well as international markets.

    • The company’s focus on research and development, product diversification, and distribution capabilities may support future business expansion initiatives.

    • Demand trends related to nutrition, wellness, food fortification, and clinical nutrition continue to shape opportunities across the markets in which the company operates.

    • Its presence across consumer, institutional, and business segments provides exposure to multiple areas of the nutrition value chain, supporting business continuity and product development efforts.

    Investment Risks and Opportunities

    Potential Risks of Investing in the IPO

    • The company operates in the nutrition and healthcare sector, where changes in regulations, quality standards, product approvals, and compliance requirements could affect business operations and product distribution.

    • A portion of the company's business is linked to domestic and international markets. Changes in demand patterns, raw material availability, supply chain disruptions, or economic conditions across key markets could influence business performance.

    Opportunities and Growth Potential

    • The company has a diversified portfolio spanning wellness nutrition, clinical nutrition, food fortification, micronutrient premixes, and ready-to-use nutrition products, providing exposure to multiple segments within the nutrition industry.

    • Growing awareness of nutrition, preventive healthcare, food fortification, and wellness products, combined with the company's research capabilities, distribution network, and international presence, may support future business expansion and product development initiatives.

     

    Key Performance Indicator (KPI)

     

    KPI

    Dec 31, 2025

    Mar 31, 2025

    ROE

    13.02%

    10.47%

    ROCE

    14.82%

    17.06%

    Debt/Equity

    0.18

    0.14

    RoNW

    12.12%

    12.46%

    PAT Margin

    9.81%

    7.36%

    EBITDA Margin

    14.03%

    12.33%

    Price to Book Value

    2.48

    2.83

    Hexagon Nutrition IPO Registrar & Lead Managers

    Registrar

    Lead Manager(s)

    Kfin Technologies Ltd.

    Cumulative Capital Pvt. Ltd., Catalyst Capital Partners Pvt. Ltd.

    Company Address of Hexagon Nutrition Ltd

    404 Global Chamber,

    Adarsh Nagar Link Road,

    Andheri (W),

    Mumbai, Maharashtra, 400053

    Phone: +91 22 6213 6710

    Email: cs.hnpl@hexagonnutrition.com

    Website: https://hexagonnutrition.com/

    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Hexagon Nutrition IPO allotment status.

     

    Frequently Asked Questions

    Published Date : 06 Jun 2026

    Disclaimer :

    Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Our Secure Trading Platforms

    Level up your stock market experience: Scan the QR to download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    9 lakh+ Users

    icon-with-text

    4.9 App Rating

    icon-with-text

    4 Languages

    icon-with-text

    ₹7,300 Cr+ MTF Book

    icon-with-text
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |